thyssenkrupp nucera Aktie

thyssenkrupp nucera für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: NCA000 / ISIN: DE000NCA0001

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Orderbuch
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
15.07.2025 09:13:13

EQS-Adhoc: thyssenkrupp nucera specifies outlook for fiscal year 2024/25 based on preliminary Q3/9M 2024/25 development and slightly raises EBIT expectation for the Group and the Chlor-Alkali segment

EQS-Ad-hoc: thyssenkrupp nucera AG & Co. KGaA / Key word(s): Change in Forecast/Preliminary Results
thyssenkrupp nucera specifies outlook for fiscal year 2024/25 based on preliminary Q3/9M 2024/25 development and slightly raises EBIT expectation for the Group and the Chlor-Alkali segment

15-Jul-2025 / 09:13 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

thyssenkrupp nucera specifies outlook for fiscal year 2024/25 based on preliminary Q3/9M 2024/25 business development and slightly raises EBIT expectation for the Group and the Chlor-Alkali segment
  • thyssenkrupp nucera AG & Co. KGaA ("thyssenkrupp nucera"), based on the preliminary business development of the first nine months of 2024/25, specifies and partially raises the outlook for the most important financial performance indicators sales and EBIT for fiscal year 2024/25 published in the combined management report 2023/24 and confirmed in the half-year financial report 2024/25.
Outlook for the 2024/25 financial year
  • At Group level, thyssenkrupp nucera now expects sales of between EUR 850 million and EUR 920 million (2023/24: EUR 862 million) and is raising the EBIT range to between EUR -7 million and EUR 7 million (2023/24: EUR -14 million). Previously, thyssenkrupp nucera had assumed sales of between EUR 850 million and EUR 950 million and EBIT of between EUR -30 million and EUR 5 million for the 2024/25 financial year.
  • In the gH2 segment, sales of between EUR 450 million and EUR 510 million (2023/24: EUR 524 million) are now expected, with EBIT of between EUR -75 million and EUR -55 million (2023/24: EUR -76 million). thyssenkrupp nucera had previously expected sales of between EUR 450 million and EUR 550 million and an improvement in EBIT to a negative mid-double-digit million euro amount.
  • In the CA segment, sales expectation continue to range from EUR 380 million to EUR 420 million (2023/24: EUR 338 million). The EBIT outlook has been raised. EBIT in the CA segment is now expected to be between EUR 55 million and EUR 75 million (2023/24: EUR 62 million). Previously, thyssenkrupp nucera had assumed a positive EBIT in the mid double-digit million euro range below the previous year's figure in the CA segment.
Preliminary business development Q3/9M 2024/25
  • Based on preliminary, unaudited figures, thyssenkrupp nucera expects sales of EUR 184 million for the third quarter of 2024/25 (Q3 2023/24: EUR 237 million). This puts Group sales below the level of the previous quarter. Sales of EUR 103 million (Q3 2023/24: EUR 134 million) are expected in the Green Hydrogen (gH2) segment and sales of EUR 81 million (Q3 2023/24: EUR 103 million) in the Chlor-Alkali (CA) segment.
  • Furthermore, thyssenkrupp nucera expects earnings before interest and taxes (EBIT) of EUR 0 million for the third quarter of 2024/25 (Q3 2023/24: EUR 2 million). EBIT in the gH2 segment rose to EUR -13 million (Q3 2023/24: EUR -23 million). EBIT in the CA segment amounted to EUR 13 million (Q3 2023/24: EUR 25 million). In the same quarter of the previous year, EBIT in the CA segment benefited from positive one-off effects.
  • This results in sales of EUR 663 million in the first nine months of 2024/25 (9M 2023/24: EUR 609 million), of which EUR 377 million is attributable to the gH2 segment (9M 2023/24: EUR 350 million) and EUR 286 million to the CA segment (9M 2023/24: EUR 259 million). Cumulative EBIT improved to EUR 4 million in the first nine months of 2024/25 (9M 2023/24: EUR -13 million). EBIT in the gH2 segment amounted to EUR -39 million (9M 2023/24: EUR -61 million) and in the CA segment to EUR 43 million (9M 2023/24: EUR 47 million).
  • Incoming orders amounted to EUR 63 million in the third quarter of 2024/25 (Q3 2023/24: EUR 271 million). Of this, EUR 13 million were attributable to the gH2 segment (Q3 2023/24: EUR 220 million) and EUR 50 million to the CA segment (Q3 2023/24: EUR 51 million). In the same period of the previous year, around EUR 200 million were recognized in incoming orders in connection with the Stegra project. The total order backlog at Group level amounted to around EUR 0.7 billion as of June 30, 2025.
All published figures and statements are preliminary and unaudited. The detailed Q3/9M 2024/25 results will be published on August 13, 2025 at 07:00 CEST.

Key financial figures: Explanations of the financial performance indicators used can be found in thyssenkrupp nucera's 2023/2024 Annual Report on pages 53 to 54, available at the following link: https://investors.thyssenkrupp-nucera.com/investors/publications


End of Inside Information

15-Jul-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
Language: English
Company: thyssenkrupp nucera AG & Co. KGaA
Freie-Vogel-Str. 385 a
44269 Dortmund
Germany
Phone: +49 231-22972-7100
E-mail: info@thyssenkrupp-nucera.com
Internet: www.thyssenkrupp-nucera.com
ISIN: DE000NCA0001
WKN: NCA000
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2169678

 
End of Announcement EQS News Service

2169678  15-Jul-2025 CET/CEST

Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!

Nachrichten zu thyssenkrupp nucera AG & Co. KGaAmehr Nachrichten

Analysen zu thyssenkrupp nucera AG & Co. KGaAmehr Analysen

16.07.25 thyssenkrupp nucera Buy Deutsche Bank AG
23.06.25 thyssenkrupp nucera Buy Deutsche Bank AG
20.06.25 thyssenkrupp nucera Outperform RBC Capital Markets
04.06.25 thyssenkrupp nucera Outperform RBC Capital Markets
04.06.25 thyssenkrupp nucera Buy Deutsche Bank AG
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Newssuche

GO

Aktien in diesem Artikel

thyssenkrupp nucera AG & Co. KGaA 10,31 0,39% thyssenkrupp nucera AG & Co. KGaA

Letzte Top-Ranking Nachrichten

05:08 Diese Aktien empfehlen Experten zu kaufen
03:32 KW 30: So performten die DAX-Aktien in der vergangenen Woche
25.07.25 KW 30: Die Gewinner und Verlierer der ATX-Aktien in der vergangenen Woche
20.07.25 Gold, Öl & Co. in KW 29: Die Tops und Flops unter den Rohstoffen
20.07.25 Bitcoin, Ether & Co. in der vergangenen Woche: Wochenbilanz der Kryptowährungen in KW 29

Börse aktuell - Live Ticker

Zollstreit zwischen EU und USA im Fokus: Wall Street zum Teil auf Rekordkurs -- ATX geht fester in Wochenende -- DAX gibt letztlich nach -- Asiens Börsen schließen schwächer
Der heimische Aktienmarkt präsentierte sich am Freitag fester. Der DAX gab am letzten Handelstag der Woche etwas nach. Die US-Börsen zeigten sich vor dem Wochenende freundlich und schafften neue teilweise Allzeithochs. An den Börsen in Fernost dominierten am Freitag die Verkäufer.
Aktien ATX  DAX  EuroStoxx 50  Dow Jones  NASDAQ 100  Nikkei 225  S&P 500 

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen